Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.

Fandos N, Pascual-Lucas M, Sarasa L, Terencio J, Sáez ME, Tartari JP, Sanabria Á, Sotolongo-Grau O, Cano A, Tárraga L, Gurruchaga MJ, Ruíz A, Montalban X, Boada M, Alegret M, Marquié M, Allué JA, FACEHBI study group, AMYPAD consortium

Open source

DOI: 10.1016/j.tjpad.2025.100465
Published: 2026 Mar
Container: The journal of prevention of Alzheimer's disease
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tjpad.2025.100465,
  title = {Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.},
  author = {Fandos N and Pascual-Lucas M and Sarasa L and Terencio J and Sáez ME and Tartari JP and Sanabria Á and Sotolongo-Grau O and Cano A and Tárraga L and Gurruchaga MJ and Ruíz A and Montalban X and Boada M and Alegret M and Marquié M and Allué JA and FACEHBI study group and AMYPAD consortium},
  year = {2026},
  journal = {The journal of prevention of Alzheimer's disease},
  doi = {10.1016/j.tjpad.2025.100465},
  url = {https://doi.org/10.1016/j.tjpad.2025.100465}
}

RIS

TY  - JOUR
TI  - Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.
AU  - Fandos N
AU  - Pascual-Lucas M
AU  - Sarasa L
AU  - Terencio J
AU  - Sáez ME
AU  - Tartari JP
AU  - Sanabria Á
AU  - Sotolongo-Grau O
AU  - Cano A
AU  - Tárraga L
AU  - Gurruchaga MJ
AU  - Ruíz A
AU  - Montalban X
AU  - Boada M
AU  - Alegret M
AU  - Marquié M
AU  - Allué JA
AU  - FACEHBI study group
AU  - AMYPAD consortium
PY  - 2026
JO  - The journal of prevention of Alzheimer's disease
DO  - 10.1016/j.tjpad.2025.100465
UR  - https://doi.org/10.1016/j.tjpad.2025.100465
ER  -

APA

N, F., M, P., L, S., J, T., ME, S., JP, T., Á, S., O, S., A, C., L, T., MJ, G., A, R., X, M., M, B., M, A., M, M., JA, A., group, F. S., & consortium, A. (2026). Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.. The journal of prevention of Alzheimer's disease. https://doi.org/10.1016/j.tjpad.2025.100465

Source records

pubmed · retrieved 2026-09-27T09:56:31.994Z
europe-pmc · retrieved 2026-09-27T09:56:31.992Z
doaj · retrieved 2026-09-27T09:56:32.010Z